The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring
Open accessAbstract
Purpose: To review information on the use of laboratory tests in screening, diagnosis, and monitoring of acute and chronic hepatic injury. Data Sources and Study Selection: A MEDLINE search was performed for key words related to hepatic diseases, including acute hepatitis, chronic hepatitis, alcoholic hepatitis, cirrhosis, hepatocellular carcinoma, and etiologic causes. Abstracts were reviewed, and articles discussing use of laboratory tests selected for review. Additional articles were selected from the references. Guideline Preparation and Review: Drafts of the guidelines were posted on the Internet, presented at the AACC Annual Meeting in 1999, and reviewed by experts. Areas requiring further amplification or literature review were identified for further analysis. Specific recommendations were made based on analysis of published data and evaluated for strength of evidence and clinical impact. Recommendations: Although many specific recommendations are made in the guidelines, only some summary recommendations are listed here. In acute hepatic injury, prothrombin time and, to a lesser extent, total bilirubin are the best indicators of severity of disease. Although ALT is useful for detecting acute and chronic hepatic injury, it is not related to severity of acute hepatic injury and only weakly related to severity of chronic hepatic injury. Specific tests of viral markers should be the initial differential tests in both acute and chronic hepatic injury; when positive, they are also useful for monitoring recovery from hepatitis B and C.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011 · cited 1×
“At best, ALT explains only 30–50% of the variation in histologic activity, and there is considerable overlap in values in patients with mild, moderate, or severe activity (158–160), which relates to rate of progression of fibrosis (162).”
BackgroundRising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Poynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene
Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., & Cox, D. W. (1993) · Nature Genetics · doi:10.1038/ng1293-327 · Cited by 1,948
A One-Year Trial of Lamivudine for Chronic Hepatitis B
Lai, C.-L., Chien, R.-N., Leung, N. W. Y., Chang, T.-T., Guan, R., Tai, D.-I., Ng, K.-Y., Wu, P.-C., Dent, J. C., Barber, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390201 · Cited by 1,754
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent
Linnen, J., Wages, J., Zhang-Keck, Z.-Y., Fry, K. E., Krawczynski, K. Z., Alter, H., Koonin, E., Gallagher, M., Alter, M., Hadziyannis, S., et al. (1996) · Science · doi:10.1126/science.271.5248.505 · Cited by 1,359
Nishizawa, T., Okamoto, H., Konishi, K., Yoshizawa, H., Miyakawa, Y., & Mayumi, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7765 · Cited by 1,234
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Epidemiology of Primary Liver Cancer
Bosch, F., Ribes, J., & Borràs, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007117 · Cited by 958
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
McMahon, B. J., Alward, W. L. M., Hall, D. B., Heyward, W. L., Bender, T. R., Francis, D. P., & Maynard, J. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.4.599 · Cited by 832
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332501 · Cited by 800
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746 · cited 10×
“Total bilirubin .257 mmol/L (15 mg/dL) or PT .3 s above the upper reference limit (29 ) in patients with viral hepatitis ALP, alkaline phosphatase (EC 3.1.3.1); PT, prothrombin time; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HBc, hepatitis B virus core antigen; HBsAg, hepatitis B virus su…”
BackgroundInfluentialA Population-Based Study of the Clinical Expression of the Hemochromatosis Gene
Olynyk, J. K., Cullen, D. J., Aquilia, S., Rossi, E., Summerville, L., & Powell, L. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411002 · Cited by 702
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Structure and variation of human α1–antitrypsin
Carrell, R. W., Jeppsson, J.-O., Laurell, C.-B., Brennan, S. O., Owen, M. C., Vaughan, L., & Boswell, D. R. (1982) · Nature · doi:10.1038/298329a0 · Cited by 617
Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma
Liebman, H. A., Furie, B. C., Tong, M. J., Blanchard, R. A., Lo, K.-J., Lee, S.-D., Coleman, M. S., & Furie, B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102204 · Cited by 617
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
Sheth, S. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00009-9 · Cited by 583
Alter, H. J., Nakatsuji, Y., Melpolder, J., Wages, J., Wesley, R., Shih, J. W.-K., & Kim, J. P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361102 · Cited by 579
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2027 · Cited by 571
Self-citationThe Wilson disease gene: spectrum of mutations and their consequences
Thomas, G. R., Forbes, J. R., Roberts, E. A., Walshe, J. M., & Cox, D. W. (1995) · Nature Genetics · doi:10.1038/ng0295-210 · Cited by 568
Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to Cirrhosis
Williams, A. L. B., & Hoofnagle, J. H. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80022-2 · Cited by 513
Sheth, S. G., Gordon, F. D., & Chopra, S. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00008 · Cited by 513
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290311 · Cited by 475
Sorbi, D. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00061-1 · Cited by 466
Zimmerman, H. J., & Maddrey, W. C. (1995) · Hepatology · doi:10.1002/hep.1840220312 · Cited by 460
The SGOT/SGPT ratio?An indicator of alcoholic liver disease
Cohen, J. A., & Kaplan, M. M. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01324898 · Cited by 450
Barbara, L., Benzi, G., Gaiani, S., Fusconi, F., Zironi, G., Siringo, S., Rigamonti, A., Barbara, C., Grigioni, W., Mazziotti, A., et al. (1992) · Hepatology · doi:10.1002/hep.1840160122 · Cited by 431
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications
Sheu, J.-C., Sung, J.-L., Chen, D.-S., Yang, P.-M., Lai, M.-Y., Lee, C.-S., Hsu, H.-C., Chuang, C.-N., Yang, P.-C., Wang, T.-H., et al. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90324-5 · Cited by 427
Screening for hepatocellular carcinoma
Collier, J., & Sherman, M. (1998) · Hepatology · doi:10.1002/hep.510270140 · Cited by 425
Noninvasive diagnosis of hepatic fibrosis or cirrhosis
Oberti, F., Valsesia, E., Pilette, C., Rousselet, M., Bedossa, P., Aube, C., Gallois, Y., Rifflet, H., Maiga, M., Penneau-Fontbonne, D., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352863 · Cited by 375
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Oka, H., Tamori, A., Kuroki, T., Kobayashi, K., & Yamamoto, S. (1994) · Hepatology · doi:10.1002/hep.1840190111 · Cited by 370
Fattovich, G., Giustina, G., Schalm, S. W., Hadziyannis, S., Sanchez-Tapias, J., Almasio, P., Christensen, E., Krogsgaard, K., Degos, F., De Moura, M. C., et al. (1995) · Hepatology · doi:10.1002/hep.1840210114 · Cited by 369
Poynard, T., McHutchison, J., Goodman, Z., Ling, M.-H., & Albrecht, J. (2000) · Hepatology · doi:10.1002/hep.510310131 · Cited by 368
Sarasin, F. P., Giostra, E., & Hadengue, A. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00197-0 · Cited by 368
Sherman, M., Peltekian, K. M., & Lee, C. (1995) · Hepatology · doi:10.1002/hep.1840220210 · Cited by 357
FREQUENCY OF ILLNESS ASSOCIATED WITH EPIDEMIC HEPATITIS A VIRUS INFECTIONS IN ADULTS
LEDNAR, W. M., LEMON, S. M., KIRKPATRICK, J. W., REDFIELD, R. R., FIELDS, M. L., & KELLEY, P. W. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114093 · Cited by 343
Frequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Liaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
Witte, D. L., Crosby, W. H., Edwards, C. Q., Fairbanks, V. F., & Mitros, F. A. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06212-2 · Cited by 321
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., & Beaugrand, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80468-4 · Cited by 296
PRIMARY BILIARY CIRRHOSIS: IDENTIFICATION OF TWO MAJOR M2 MITOCHONDRIAL AUTOANTIGENS
Yeaman, S. J., Danner, D. J., Mutimer, D. J., Fussey, S. P. M., James, O. F. W., & Bassendine, M. F. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91894-6 · Cited by 293
The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers
de Franchis, R., Meucci, G., Vecchi, M., Tatarella, M., Colombo, M., Del Ninno, E., Rumi, M. G., Donato, M. F., & Ronchi, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00006 · Cited by 292
Molecular medicine and hemochromatosis: At the crossroads
Bacon, B. R., Powell, L. W., Adams, P. C., Kresina, T. F., & Hoofnagle, J. H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70244-1 · Cited by 286
Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology · doi:10.1002/hep.510290409 · Cited by 278
Hereditary Hemochromatosis: Gene Discovery and Its Implications for Population-Based Screening
Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., Barton, J. C., Beutler, E., Brittenham, G., Buchanan, A., et al. (1998) · JAMA · doi:10.1001/jama.280.2.172 · Cited by 276
EASL International Consensus Conference on Hepatitis C
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80366-3 · Cited by 268
Hultcrantz, R., Glaumann, H., Lindberg, G., & H:son Nilsson, L. (1986) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528609034632 · Cited by 261
A Serologic Follow-up of the 1942 Epidemic of Post-Vaccination Hepatitis in the United States Army
Seeff, L. B., Beebe, G. W., Hoofnagle, J. H., Norman, J. E., Buskell-Bales, Z., Waggoner, J. G., Kaplowitz, N., Koff, R. S., Petrini, J. L., Schiff, E. R., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704163161601 · Cited by 254
Self-citationBonacini, M., Hadi, G., Govindarajan, S., & Lindsay, K. L. (1997) · PubMed · Cited by 250
The Natural History of Liver Disease in (α1‐Antitrypsin Deficient Children
SVEGER, T. (1988) · Acta Paediatrica · doi:10.1111/j.1651-2227.1988.tb10767.x · Cited by 245
Guéchot, J., Laudat, A., Loria, A., Serfaty, L., Poupon, R., & Giboudeau, J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.4.558 · Cited by 239
Seroreactivity to hepatitis E virus in areas where the disease is not endemic
Thomas, D. L., Yarbough, P. O., Vlahov, D., Tsarev, S. A., Nelson, K. E., Saah, A. J., & Purcell, R. H. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.5.1244-1247.1997 · Cited by 230
Evaluation of assays for antibody to hepatitis E virus by a serum panel
Mast, E. E., Alter, M. J., Holland, P. V., & Purcell, R. H. (1998) · Hepatology · doi:10.1002/hep.510270331 · Cited by 229
Progressive Liver Functional Impairment Is Associated with an Increase in AST/ALT Ratio
Giannini, E., Botta, F., Fasoli, A., Ceppa, P., Risso, D., Lantieri, P. B., Celle, G., & Testa, R. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026609231094 · Cited by 224
Pinto, H. C., Baptista, A., Camilo, M. E., Valente, A., Saragoça, A., & de Moura, M. C. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02208601 · Cited by 219
Relapsing Hepatitis A Review of 14 Cases and Literature Survey
Glikson, M., Galun, E., Oren, R., Tur-Kaspa, R., & Shouval, D. (1992) · MEDICINE · doi:10.1097/00005792-199201000-00002 · Cited by 216
Is Liver Biopsy Useful in the Evaluation of Patients with Chronically Elevated Liver Enzymes?
Van Ness, M. M., & Diehl, A. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-6-473 · Cited by 213
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases
Mulder, A. (1993) · Hepatology · doi:10.1016/0270-9139(93)90052-o · Cited by 212
OLEOANILIDES AND SPANISH OIL POISONING
Gordon, R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90621-8 · Cited by 207
Viremia, Fecal Shedding, and IgM and IgG Responses in Patients with Hepatitis E
Clayson, E. T., Myint, K. S. A., Snitbhan, R., Vaughn, D. W., Innis, B. L., Chan, L., Cheung, P., & Shrestha, M. P. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.4.927 · Cited by 188
Clinical Manifestations Of Hepatitis A: Recent Experience In A Community Teaching Hospital
Tong, M. J., El-Farra, N. S., & Grew, M. I. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s15 · Cited by 181
Shiraki, K., Takase, K., Tameda, Y., HAMADA, M., Kosaka, Y., & Nakano, T. (1995) · Hepatology · doi:10.1002/hep.1840220317 · Cited by 180
Hepatitis B: diagnosis, prevention, and treatment
Gitlin, N. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1500 · Cited by 179
Cottone, M., Turri, M., Caltagirone, M., Parisi, P., Orlando, A., Fiorentino, G., Virdone, R., Fusco, G., Grasso, R., Simonetti, R. G., et al. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80613-0 · Cited by 179
Neuberger, J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05419-6 · Cited by 179
Hepatitis A Virus in Stool During Clinical Relapse
SJOGREN, M. H., TANNO, H., FAY, O., SILEONI, S., COHEN, B. D., BURKE, D. S., & FEIGHNY, R. J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-221 · Cited by 171
Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure.
Harrison, P. M., O'Grady, J. G., Keays, R. T., Alexander, G. J., & Williams, R. (1990) · BMJ · doi:10.1136/bmj.301.6758.964 · Cited by 170
Crawford, D. H. G., Jazwinska, E. C., Cullen, L. M., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70320-8 · Cited by 167
A prospective study of the causes of notably raised aspartate aminotransferase of liver origin
Whitehead, M. W., Hawkes, N. D., Hainsworth, I., & Kingham, J. G. C. (1999) · Gut · doi:10.1136/gut.45.1.129 · Cited by 166
Autoimmune hepatitis: Evolving concepts and treatment strategies
Czaja, A. J. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065434 · Cited by 160
Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis
Czaja, A. J., Carpenter, H. A., & Manns, M. P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90160-e · Cited by 155
Increased risk of chronic liver failure in adults with heterozygous α-antitrypsin deficiency
Graziadei, I. W., Joseph, J. J., Wiesner, R. H., Therneau, T. M., Batts, K. P., & Porayko, M. K. (1998) · Hepatology · doi:10.1002/hep.510280421 · Cited by 151
Mathiesen, U. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950172880 · Cited by 150
Relationship of aminotransferases to liver histological status in chronic hepatitis C.
Haber, M. M., Ab, W., Ad, H., & Reuben, A. (1995) · PubMed · Cited by 149
Adams, P. C., Gregor, J. C., Kertesz, A. E., & VALBERG, L. S. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90283-x · Cited by 146
Hay, E. J., Czaja, A. J., Rakela, J., & Ludwig, J. (1989) · Hepatology · doi:10.1002/hep.1840090205 · Cited by 145
Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin
Cauza, E., Maier-Dobersberger, T., Polli, C., Kaserer, K., Kramer, L., & Ferenci, P. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80182-1 · Cited by 138
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
Chapman, R. W., Cottone, M., Selby, W. S., Shepherd, H. A., Sherlock, S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.1.86 · Cited by 135
Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis
Williams, B. A., & Hoofnagle, J. H. (1988) · Cited by 133
Benhamou, J. P., Alter, H. J., & Rodés‐Cabau, J. (1999) · PubMed · Cited by 124
Nguyen, T. T., Sedghi-Vaziri, A., Wilkes, L. B., et al. (1996) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1996.tb00084.x · Cited by 123
Adams, P. C., Kertesz, A. E., McLaren, C. E., Barr, R., Bamford, A., & Chakrabarti, S. (2000) · Hepatology · doi:10.1053/he.2000.6984 · Cited by 120
Serum Enzyme Tests in Diseases of the Liver and Biliary Tree
Ellis, G., Goldberg, D. M., Spooner, R. J., & Ward, M. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/70.2.248 · Cited by 117
Plasma abnormal prothrombin (Des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
Fujiyama, S., Morishita, T., Hashiguchi, O., & Sato, T. (1988) · Cancer · doi:10.1002/1097-0142(19880415)61:8<1621::aid-cncr2820610820>3.0.co;2-c · Cited by 116
Asymptomatic hepatocellular carcinoma in Child's A cirrhosis
Cottone, M., Virdone, R., Fusco, G., et al. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90528-3 · Cited by 116
Healey, C. J., Chapman, R. W., & Fleming, K. A. (1995) · Gut · doi:10.1136/gut.37.2.274 · Cited by 115
McCormick, S. E., Goodman, Z., Maydonovitch, C. L., & Sjögren, M. H. (1996) · PubMed · Cited by 110
Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening
Cogswell, M. E., McDonnell, S. M., Khoury, M. J., Franks, A. L., Burke, W., & Brittenham, G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_2-199812011-00008 · Cited by 108
Loriot, M., Marcellin, P., Walker, F., Boyer, N., Degott, C., Randrianatoavina, I., Benhamou, J., & Erlinger, S. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80168-7 · Cited by 105
Hepatic dysfunction accompanying acute cocaine intoxication
Silva, M., Roth, D., Reddy, K. R. R. M., Fernandez, J., Albores‐Saavedra, J., & Schiff, E. R. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90832-v · Cited by 102
Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value
Körner, T. W., Kropf, J., & Gressner, A. M. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80239-x · Cited by 100
Singer, A. J., Caraccio, T. R., & Mofenson, H. C. (1995) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(95)70237-7 · Cited by 100
Fattovich, G. (1995) · Hepatology · doi:10.1016/0270-9139(95)90411-5 · Cited by 97
Assessment of Prognosis in Fulminant Hepatic Failure
Tygstrup, N., & Ranek, L. (1986) · Seminars in Liver Disease · doi:10.1055/s-2008-1040596 · Cited by 95
Prevalence of heterozygotes for hemochromatosis in the white population of the United States
McLaren, C., Gordeuk, V., Looker, A., Hasselblad, V., Edwards, C., Griffen, L. M., Kushner, J. P., & Brittenham, G. (1995) · Blood · doi:10.1182/blood.v86.5.2021.bloodjournal8652021 · Cited by 93
Seeff, L. B., Wright, E. C., Zimmerman, H. J., & McCollum, R. W. (1975) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197509000-00018 · Cited by 92
Self-citationEvaluation of Blood Donors with Elevated Serum Alanine Aminotransferase Levels
Friedman, L. S., Dienstag, J. L., WATKINS, E., HINKLE, C. A., SPIERS, J. A., RIEDER, S. V., & HUGGINS, C. E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-137 · Cited by 92
Kundrotas, L. W., & Clement, D. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01299887 · Cited by 89
Inglesby, T. V., Rai, R., Astemborski, J. A., Gruskin, L., Nelson, K. E., Vlahov, D., & Thomas, D. L. (1999) · Hepatology · doi:10.1002/hep.510290219 · Cited by 88
Prospective study of clinical and biochemical features of symptomatic choledocholithiasis
Anciaux, M. L., Pelletier, G., Attali, P., Meduri, B., Liguory, C., & Etienne, J. P. (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01320306 · Cited by 82
Mendenhall, C. L., MORITZ, T. E., Rouster, S. D., Roselle, G. A., Polito, A., Quan, S., & Rk, D. (1993) · PubMed · Cited by 80
Pontisso, P., Bellati, G., Brunetto, M. R., Chemello, L., Colloredo, G., Stefano, R. D., Nicoletti, M., Rumi, M. G., Ruvoletto, M. G., Soffredini, R., et al. (1999) · Hepatology · doi:10.1002/hep.510290240 · Cited by 74
Izzo, F., Cremona, F., Ruffolo, F., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199804000-00011 · Cited by 73
Src activation in malignant and premalignant epithelia of Barrett's esophagus
Kumble, S., Omary, M. B., Cartwright, C., & Triadafilopoulos, G. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024288 · Cited by 72
Prognostic significance of cholestatic alcoholic hepatitis
Nissenbaum, M. M., Chedid, A., Mendenhall, C. L., Gartside, P. S., & VA Cooperative Study Group #119 (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01536804 · Cited by 70
Workshop on Screening for Hepatocellular Carcinoma
McMahon, B. J., & London, T. W. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.13.916 · Cited by 69
Primary Sclerosing Cholangitis: A Clinical Review
Ponsioen, C. Y., & Tytgat, G. N. J. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00034-3 · Cited by 68
Crapper, R. M., Bhathal, P. S., Mackay, I. R., & Frazer, I. H. (2009) · Digestion · doi:10.1159/000199332 · Cited by 68
Cammà, C., Giunta, M., Pinzello, G., Morabito, A., Verderio, P., & Pagliaro, L. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00800-4 · Cited by 64
Lu, S. C.-L., Huang, Z., Yang, J. M., & Tsukamoto, H. (1999) · Hepatology · doi:10.1002/hep.510300134 · Cited by 60
Roozendaal, C., de Wit, A. W. M. V. M., Haagsma, E. B., Horst, G., Schwarze‐Zander, C., Peter, H. H., Kleibeuker, J. H., Tervaert, J. W. C., Limburg, P. C., & Kallenberg, C. G. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00294-0 · Cited by 60
α1‐antitrypsin deficiency and liver disease
Birrer, P., McElvaney, N. G., Chang‐Stroman, L. M., & Crystal, R. G. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01797921 · Cited by 54
Ruiz-Moreno, M., Otero, M., Millán‐Jiménez, A., Castillo, I., Cabrerizo, M., Jiménez, J. I. J., Oliva, H., y Cajal, S. R., & Carréño, V. (1999) · Hepatology · doi:10.1002/hep.510290230 · Cited by 54
HEPATOTOXICITY OF ANALGESICS AND ANTI-INFLAMMATORY AGENTS
Fry, S. W., & Seeff, L. B. (1995) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00232-6 · Cited by 53
Self-citationEfficacy of serum laminin measurement for diagnosis of fibrotic liver diseases.
Kröpf, J., Gressner, A. M., & Negwer, A. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.10.2026 · Cited by 51
Fanning, L. J., Kenny-Walsh, E., Levis, J., Choudhury, K. R., Cannon, B., Sheehan, M., Whelton, M. J., & Shanahan, F. (2000) · Hepatology · doi:10.1002/hep.510310133 · Cited by 49
Beld, M., Penning, M. T., McMorrow, M., Gorgels, J. P. M. C., van den Hoek, A., & Goudsmit, J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.872-877.1998 · Cited by 46
Gordon, S. C., Dailey, P. J., Silverman, A. L., Khan, B. A., Kodali, V. P., & Wilber, J. C. (1998) · Hepatology · doi:10.1002/hep.510280634 · Cited by 44
Neuberger, J. (2011) · Medicine · doi:10.1016/j.mpmed.2011.07.010 · Cited by 43
Davis, G. L., Czaja, A. J., Baggenstoss, A. H., & Taswell, H. F. (1982) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)14130-x · Cited by 40
Tsutsumi, M., Takase, S., Urashima, S., Ueshima, Y., Kawahara, H., & Takada, A. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01692.x · Cited by 38
Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis
Czaja, A. J., Magrin, S., Fabiano, C., Fiorentino, G., Diquattro, O., Craxı̀, A., & Pagliaro, L. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02063938 · Cited by 37
Prothrombin Time in Fulminant Hepatic Failure
Muñoz, S. J. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90822-3 · Cited by 34
Eiras-Hreha, G., Jefferson, D. M., Yu, C., Grubman, S. A., Alsabeh, R., Geller, S. A., & Vierling, J. M. (1999) · Hepatology · doi:10.1002/hep.510300216 · Cited by 28
Rozen, P., Korn, R. J., & Zimmerman, H. J. (1971) · PubMed · Cited by 27
The Epidemiology of Hepatitis Viruses B, C, and D
London, W. T., & Evans, A. A. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30268-3 · Cited by 26
Hollingsworth, R. C., Minton, E. J., Fraser‐Moodie, C., Metivier, E., Rizzi, P. M., Irving, W. L., Jenkins, D., & Ryder, S. D. (1998) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1998.00102.x · Cited by 17
Falleti, E., Pirisi, M., Fabris, C., Bortolotti, N., Soardo, G., Gonano, F., & Bartoli, E. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00135-x · Cited by 15
A Quarter-Century of Antiviral Therapy
Merigan, T. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332509 · Cited by 10
Chapter 10 Hereditary Disorders of Copper Metabolism
Tümer, Z., & Horn, N. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60030-9 · Cited by 5
Milman, N. T., & Albeck, M. J. (1995) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1995.33.2.95 · Cited by 5
Cited by
Liver enzyme alteration: a guide for clinicians
Giannini, E. G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040752 · Cited by 2,016
The current state of serum biomarkers of hepatotoxicity
Ozer, J., Ratner, M., Shaw, M., Bailey, W., & Schomaker, S. (2008) · Toxicology · doi:10.1016/j.tox.2007.11.021 · Cited by 1,269
ACG clinical guideline: evaluation of abnormal liver chemistries
Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.517 · Cited by 1,222
Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury
Laterza, O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., Johnson, J. M., Sina, J. F., Fare, T. L., Sistare, F. D., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.131797 · Cited by 619
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2027 · Cited by 571
Self-citation
Metadata
- Authors
- Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-12-01
- Volume
- 46
- Issue
- 12
- Pages
- 2050-2068
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2115692333
- Cited by
- 439
- References
- 148
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.